The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies

scientific article

The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000441542
P932PMC publication ID4698643
P698PubMed publication ID26733769

P50authorThomas MüllerQ63788179
P2093author name stringAndrea Doescher
Eduard K Petershofen
Paul V Haydock
Russ Aldrich
Thomasz Adamczyk
P2860cites workGenotyping fetal DNA by non-invasive means: extraction from maternal plasmaQ31920253
Capture of genomic DNA on glass microscope slidesQ35954816
Non-invasive antenatal RHD typingQ36431820
Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyQ36538133
Molecular prenatal diagnosis: the impact of modern technologies.Q37767195
Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.Q40380350
Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping serviceQ40626763
Evaluation of sample stability and automated DNA extraction for fetal sex determination using cell-free fetal DNA in maternal plasmaQ43599210
Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit.Q44779251
Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.Q45984957
Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.Q50792929
Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.Q51899817
Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.Q53597278
Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days.Q54342228
The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.Q54520641
Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.Q54646324
Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.Q54677055
Fetal RhD genotyping by maternal serum analysis: a two-year experience.Q54677407
Clinical applications of cell-free fetal DNA from maternal plasma.Q54735498
Prenatal genotyping of RHD and SRY using maternal blood.Q54741354
Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care.Q54778477
Presence of fetal DNA in maternal plasma and serumQ57075132
Determination of fetal RhD status by maternal plasma DNA analysisQ73808672
Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCRQ77332308
Detection of fetal RHD-specific sequences in maternal plasmaQ77429872
Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experienceQ79362850
P433issue6
P304page(s)379-384
P577publication date2015-10-26
P1433published inTransfusion Medicine and HemotherapyQ15758504
P1476titleThe Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies
P478volume42

Search more.